select
studi
singl
antigenspecif
b
cell
identif
express
antibodi
help
shed
light
natur
function
human
humor
immun
respons
studi
present
antigenconjug
fluoresc
bead
methodolog
design
identifi
isol
singl
antibodyexpress
cell
deriv
clone
match
heavi
light
chain
antibodi
variabl
region
full
length
antibodi
believ
singl
celltofunct
antibodi
strategi
fall
within
scope
research
topic
open
way
opportun
analyz
b
cell
antibodi
profil
singl
cell
level
may
potenti
appli
help
unravel
divers
humor
immun
repertoir
differ
health
diseas
state
studi
humor
immun
may
key
understand
human
health
age
diseas
well
predict
monitor
host
immun
respons
pathogen
challeng
diseas
progress
moreov
dissect
b
cell
respons
could
help
inform
medic
intervent
prevent
vaccin
therapeut
treatment
current
therapeut
monoclon
antibodi
part
standard
care
treatment
variou
condit
includ
diabet
autoimmun
allerg
diseas
variou
type
cancer
big
proport
antibodi
fulli
mous
chimera
therefor
identif
fulli
human
heavi
h
light
l
variabl
regionmatch
antibodi
may
interest
clinic
applic
administr
fulli
human
antibodi
consid
less
like
induc
antidrug
antibodi
respons
compar
chimer
human
antibodi
immun
monitor
human
b
cell
recogn
specif
antigen
alongsid
identif
clone
product
cognat
monoclon
antibodi
may
therefor
substanti
valu
help
evalu
reactiv
immunolog
respons
antigen
analys
antibodi
repertoir
b
cell
report
human
set
anim
model
common
applic
studi
autoimmun
diseas
viral
infect
b
cell
malign
studi
employ
highthroughput
sequenc
heavi
chain
variabl
region
pair
h
l
variabl
region
sequenc
ultrahighthroughput
sequenc
techniqu
also
develop
capabl
analyz
repertoir
thousand
b
cell
small
human
blood
sampl
allow
map
pair
h
l
variabl
region
hour
b
cell
may
also
sourc
antigenspecif
antibodi
clinic
diagnost
therapeut
applic
exist
method
identifi
antigenspecif
b
cell
gener
monoclon
antibodi
includ
ex
vivo
b
cell
cultur
approach
could
promot
surviv
expans
certain
b
cell
subset
screen
cultur
supernat
identifi
b
cell
reactiv
fluorescentactiv
cell
sort
essenti
element
process
select
antigenspecif
b
cell
detect
antibodi
certain
degre
specif
could
achiev
screen
cell
cultur
supernat
elispot
assay
elisabas
method
use
immobil
recombin
antigen
cell
screen
cell
cultur
supernat
elisa
although
highli
sensit
repres
surrog
paramet
antigen
reactiv
ultim
confirm
sequenc
express
select
clone
applic
gold
standard
identifi
antigenspecif
antibodi
remain
express
recombin
antibodi
evalu
antigen
recognit
properti
workflow
facilit
select
singl
human
b
cell
without
ex
vivo
growth
stimul
clone
expans
requir
sampl
cell
cultur
supernat
could
offer
addit
tool
studi
human
b
cell
immun
novel
approach
address
requir
involv
use
modifi
fluoresc
tetram
direct
b
cell
screen
fluorescentactiv
cell
sort
studi
describ
design
beadbas
methodolog
identifi
singl
antibodyexpress
b
cell
clone
produc
antigenspecif
antibodi
workflow
featur
beadbas
identif
isol
specif
b
cell
use
direct
fluorescentactiv
cell
sort
sequenc
clone
match
heavi
light
chain
variabl
region
singl
full
sequenc
antibodi
express
vector
system
express
test
antigen
reactiv
antibodi
clone
workflow
design
avoid
ex
vivo
b
cell
expans
secondari
clone
select
facilit
antibodi
gener
downstream
evalu
human
immun
cell
isol
venou
blood
healthi
volunt
patient
malign
melanoma
specimen
collect
inform
written
consent
accord
declar
helsinki
studi
conduct
king
colleg
london
king
colleg
london
guy
st
thoma
nh
foundat
trust
approv
london
bridg
nre
committe
approv
londoncentr
nre
committe
human
peripher
blood
mononuclear
cell
pbmc
isol
ml
blood
use
paqu
plu
densiti
centrifug
ge
healthcar
cell
cultur
perform
use
asept
techniqu
humidifi
atmospher
unless
otherwis
specifi
human
ovarian
carcinoma
cell
line
natur
overexpress
folat
receptor
alpha
grown
rpmi
medium
thermo
scientif
supplement
fetal
calf
serum
fc
human
breast
cancer
cell
line
grown
dmem
medium
thermo
scientif
supplement
fc
perman
transfect
murin
myeloma
cell
line
specif
recogn
colon
carcinoma
antigen
cultur
dulbecco
modifi
eagl
medium
plu
fc
previous
describ
human
embryon
kidney
cell
line
cell
cultur
serumfre
express
medium
thermo
scientif
stuart
orbit
shaker
rpm
cell
transfect
antibodi
construct
use
transfect
kit
thermo
scientif
per
manufactur
instruct
antihuman
epiderm
growth
factor
receptor
melanomaassoci
antigenspecif
chondroitin
sulfat
proteoglycan
antibodi
construct
previous
describ
differ
avidin
streptavidinco
fluoresc
bead
differ
size
use
tabl
supplementari
materi
xmap
lumavidin
microspher
lumavidin
size
fluoresc
apc
channel
luminex
sphero
coatedfluoresc
particl
spherotec
inc
follow
sphero
streptavidinco
fluoresc
particl
nile
red
sare
cat
sphero
avidinco
fluoresc
particl
nile
red
are
cat
sphero
streptavidinco
fluoresc
particl
blue
sablu
cat
biotinyl
protein
melanoma
cell
line
confluent
cell
monolay
wash
pb
borat
buffer
ph
sulfonhslcbiotin
mgml
pb
ad
incub
min
ice
reaction
quench
mm
tri
mm
nacl
ph
cell
subsequ
extens
wash
pb
cell
lysi
buffer
cell
signal
technolog
contain
triton
supplement
mm
pmsf
ad
monolay
cell
harvest
scrap
lysat
briefli
sonic
incub
orbit
rocker
min
c
lysat
clear
centrifug
g
min
follow
second
centrifug
g
min
supernat
either
use
immedi
store
recombin
folat
receptor
r
system
cat
human
epiderm
growth
factor
receptor
fc
chimera
r
system
cat
reconstitut
pb
mgml
recommend
manufactur
biotin
three
differ
arm
use
sulfonhslcbiotin
spacer
arm
ii
sulfonhslclcbiotin
spacer
arm
iii
spacer
arm
piercethermo
fisher
scientif
three
form
biotin
reconstitut
follow
manufactur
instruct
mix
recombin
protein
pb
biotin
recombin
protein
molar
ratio
incub
min
room
temperatur
rt
free
biotin
remov
dialysi
pb
bind
biotinconjug
lumavidin
microspher
microspher
solut
wash
ml
sodium
azid
spun
g
min
pellet
resuspend
sodium
azid
biotinconjug
recombin
protein
bsa
ad
bead
mix
rotat
h
rt
bead
wash
three
time
ml
sodium
azid
resuspend
sodium
azid
bind
biotinconjug
sphero
fluoresc
particl
bead
wash
ml
sodium
azid
spun
g
min
rt
pellet
resuspend
origin
volum
bead
sodium
azid
biotinconjug
recombin
protein
ad
mix
rotat
h
rt
bind
bead
wash
three
time
ml
sodium
azid
resuspend
sodium
azid
bind
biotinconjug
cell
extract
lumavidin
microspher
microspher
solut
wash
ml
sodium
azid
spun
g
min
pellet
resuspend
sodium
azid
biotinconjug
cell
extract
ad
bead
mix
rotat
h
rt
bind
bead
wash
three
time
ml
sodium
azid
resuspend
sodium
azid
test
bead
use
check
protein
attach
bead
surfac
conjug
bead
stain
specif
antibodi
conjug
bead
incub
fac
buffer
min
rt
monoclon
antibodi
previous
describ
ref
isotyp
control
antibodi
ad
describ
experi
haptenspecif
inhous
produc
monoclon
antibodi
antinip
igg
use
isotyp
control
bead
incub
min
wash
ml
fac
buffer
incub
antihuman
immunoglobulin
ig
antibodi
conjug
fitc
vector
laboratori
anoth
min
final
wash
fac
buffer
stain
bead
analyz
flow
cytomet
bd
bioscienc
bead
coat
melanoma
cell
line
extract
test
stain
monoclon
igg
antibodi
recogn
melanomaassoci
antigen
b
cell
transfect
antibodi
cell
transfect
transient
express
antibodi
cell
fac
buffer
incub
conjug
bead
min
rt
wash
ml
fac
buffer
left
ice
analyz
flow
cytomet
bd
bioscienc
cell
express
igg
control
antibodi
prestain
antimous
mhc
class
ipe
antibodi
use
streptavidin
sablu
lumavidin
bead
tabl
supplementari
materi
antimous
apc
antibodi
bd
bioscienc
far
cell
track
dye
thermo
fisher
scientif
use
avidin
fluoresc
are
bead
cell
express
control
antibodi
day
post
transfect
label
far
cell
track
dye
thermo
fisher
scientif
bead
coat
recombin
antigen
incub
block
buffer
unless
state
min
rt
pbmc
ad
block
buffer
spike
conduct
prelabel
cell
differ
pbmc
prelabel
cell
ratio
anoth
cell
bead
incub
min
wash
ml
fac
buffer
stain
dapi
sampl
analyz
flow
cytomet
bd
bioscienc
data
analyz
use
softwar
version
actual
dilut
calcul
divid
number
live
far
posit
event
antigenspecif
cell
number
live
far
neg
event
pbmc
cell
transfect
igg
stain
fluoresc
bead
sort
plate
cellswel
directli
lysi
buffer
singl
cell
lysi
kit
ambionthermo
fisher
scientif
use
bd
ii
cell
sorter
bd
bioscienc
nozzl
sampl
transfer
ml
pcr
tube
store
process
enrich
b
cell
obtain
ml
peripher
blood
two
patient
melanoma
use
rosettesep
human
b
cell
enrich
cocktail
stemcel
technolog
follow
manufactur
instruct
b
cell
incub
fc
block
reagent
miltenyi
biotec
min
rt
stain
fitc
fitc
anti
pe
antibodi
bd
bioscienc
simultan
incub
lumiavidin
bead
coat
melanoma
cell
extract
min
ice
sort
buffer
pb
bsa
mm
edta
immedi
acquisit
dapi
livedead
dye
ad
cell
bind
fluoresc
bead
sort
plate
cellwel
lysi
buffer
b
cell
nozzl
use
pcr
tube
contain
sort
cell
lysi
buffer
thaw
revers
transcript
perform
thermal
cycler
use
superscript
vilo
cdna
synthesi
kit
thermo
fisher
scientif
follow
manufactur
recommend
variabl
region
ig
heavi
light
chain
amplifi
two
round
pcr
amplif
mix
use
phusion
flash
polymeras
mix
per
reaction
finnzym
primer
revers
transcriptas
reaction
templat
first
pcr
first
pcr
templat
second
pcr
variabl
region
heavi
chain
cycl
amplif
min
cycl
follow
final
step
min
first
pcr
revers
primer
iggrev
constant
region
igg
second
pcr
revers
primer
variabl
region
light
chain
cycl
amplif
min
cycl
follow
final
step
min
first
pcr
revers
primer
kappar
constant
region
kappa
chain
second
pcr
revers
primer
primer
caggttcaactgcagcagtctgga
tgaggagacggtgactgaggttcc
gatatccagatgacacagactaca
tttccagcttggtgcctcc
iggrev
ccaactctcttgtccaccttgg
kappar
gtttctcgtagtctgctttgctca
forward
revers
primer
use
amplif
unknown
ig
light
heavi
chain
fragment
tabl
nest
pcr
protocol
previous
describ
pcr
product
separ
agaros
gel
purifi
use
qiaquick
gel
extract
kit
qiagen
clone
use
zeroblunt
pcr
clone
kit
life
technolog
six
coloni
grown
pcr
band
plasmid
dna
purifi
use
qiaprep
spin
miniprep
kit
qiagen
sequenc
sourc
bioscienc
use
forward
primer
sequenc
analyz
use
imgtvquest
heavi
light
chain
variabl
region
clone
invivogen
use
polymeras
incomplet
primer
extens
pipe
clone
previous
describ
brief
contain
preclon
human
antibodi
heavi
light
constant
region
cassett
gamma
use
templat
two
separ
pipe
pcr
reaction
amplifi
two
linear
plasmid
fragment
partial
singlestrand
end
similarli
ig
heavi
light
chain
variabl
region
pipe
pcramplifi
use
pcrblunt
construct
gener
previous
pcr
templat
next
pcr
product
dilut
four
time
mix
ratio
incub
rt
h
mixtur
use
transform
e
coli
cell
thermo
fisher
scientif
success
clone
confirm
sanger
sequenc
sourc
bioscienc
express
transient
cell
thermo
fisher
scientif
describ
ref
antibodi
secret
cultur
supernat
purifi
use
protein
column
thermo
fisher
scientif
store
pb
design
process
allow
identif
antigenspecif
antibodyexpress
b
cell
perform
without
prior
ex
vivo
growth
secondari
screen
b
cell
establish
system
select
folat
receptor
alpha
model
antigen
test
antibodyexpress
cell
select
b
cell
line
express
solubl
membranebound
b
cell
receptor
bcr
form
humanmous
chimer
antibodi
clone
specif
workflow
figur
entail
coupl
fluoresc
polystyren
bead
nomin
antigen
folat
receptor
alpha
follow
bind
bead
antibodyexpress
b
cell
singl
beadconjug
cell
identifi
isol
fac
sort
directli
onto
micropl
contain
lysi
buffer
rna
releas
singl
cell
convert
cdna
use
revers
transcript
follow
seminest
rtpcr
ig
specif
primer
match
variabl
h
l
chain
sequenc
clone
singl
express
vector
contain
h
l
constant
region
sequenc
previous
report
full
antibodi
express
human
express
host
antibodi
purifi
antibodi
specif
antigen
test
target
antigenexpress
cell
first
establish
workflow
use
apc
fluorochrom
lumavidin
microspher
diamet
lumavidin
tabl
supplementari
materi
prior
interrog
abil
bead
bind
antibodyexpress
cell
use
flow
cytometr
evalu
confirm
fluoresc
bead
could
success
coupl
antigen
test
antigen
conjug
fluoresc
bead
antibodi
igg
bound
bead
antibodi
trastuzumab
bound
bead
hand
haptenspecif
monoclon
antibodi
nip
igg
show
background
bind
bead
bind
detect
bead
incub
secondari
antibodi
alon
figur
also
interrog
differ
coupl
agent
vari
biotin
length
lcbiotin
lclcbiotin
assess
whether
distanc
bead
antigen
bead
surfac
could
affect
antigen
recognit
b
cell
found
signific
differ
igg
antibodi
bind
beadconjug
respect
coupl
agent
figur
establish
model
system
use
microspherecoupl
antibodyexpress
b
cell
confirm
small
proport
lumavidin
microspher
recogn
singl
antibodyexpress
b
cell
figur
singl
beadbound
cell
isol
lysi
buffercontain
micropl
well
flow
cytometr
sort
singl
cell
pcr
yield
match
h
l
chain
variabl
region
dna
product
detect
expect
size
figur
antibodi
variabl
region
sequenc
clone
vector
contain
human
constant
region
cassett
antibodi
express
cell
subsequ
clone
antibodi
use
assess
bind
cell
express
nativ
cell
surfac
human
flow
cytometr
evalu
confirm
antibodi
clone
sort
singl
antibodyexpress
b
cell
abl
specif
recogn
antigenexpress
cell
clone
antibodi
recogn
breast
carcinoma
cell
express
figur
find
confirm
possibl
extract
match
variabl
region
sequenc
singl
antibodyexpress
cell
select
recognit
specif
antigenco
microspher
select
singl
b
cell
allow
identif
expect
match
variabl
region
permit
clone
product
correspond
monoclon
antibodi
singl
cell
antibodi
abl
recogn
nativ
express
cell
surfac
sinc
observ
microspher
abl
bind
small
proport
singl
antibodyexpress
b
cell
investig
whether
microspher
diamet
bead
could
influenc
specif
recognit
antibodyexpress
cell
confirm
igg
cell
express
igg
cell
surfac
could
recogn
human
recombin
figur
observ
recombin
antibodi
bind
microspher
figur
distanc
bead
antigen
bead
surfac
affect
antigen
recognit
antibodyexpress
cell
figur
howev
proport
cell
recogn
fluoresc
bead
coat
differ
bead
size
type
microspher
smaller
bead
diamet
sare
sablu
appear
bind
higher
proport
b
cell
respect
compar
lumavidin
bead
figur
length
biotin
arm
minor
effect
bind
smaller
size
are
sablu
microspher
cell
arm
show
slightli
higher
proport
microsphereattach
cell
cell
compar
bead
attach
via
lclcbiotin
lcbiotin
arm
figur
bind
fluoresc
bead
appear
specif
antibodyexpress
b
cell
sinc
bead
bound
igg
cell
bead
bound
nonspecif
antibodyexpress
cell
use
control
figur
find
suggest
bead
size
type
could
influenc
proport
possibl
antibodyexpress
b
cell
recogn
antigenconjug
fluoresc
bead
sinc
alongsid
specif
bind
bead
antibodyexpress
b
cell
also
detect
nonspecif
bind
bead
control
cell
figur
investig
background
bind
fluoresc
bead
freshli
isol
human
pbmc
proport
human
pbmc
top
panel
also
human
b
cell
cell
lower
panel
could
bind
bead
like
nonspecif
manner
figur
differ
block
agent
appear
reduc
level
background
bind
tabl
supplementari
materi
furthermor
are
sablu
lumavidin
bead
incub
pbmc
bind
directli
compar
recognit
igg
cell
use
posit
control
are
microspher
show
specif
nonspecif
b
cell
recognit
sablu
microspher
show
specif
nonspecif
recognit
b
cell
hand
larger
size
lumavidin
microspher
show
specif
nonspecif
bind
figur
suggest
smaller
diamet
bead
like
select
antibodyexpress
cell
order
analyz
whether
frequenc
antibodyexpress
b
cell
pbmc
sampl
may
detect
bead
spike
human
pbmc
cell
differ
frequenc
detect
doubleposit
event
flow
cytometri
figur
are
fluoresc
bead
incub
pbmc
pbmc
tabl
supplementari
materi
presenc
serial
dilut
cell
prelabel
antibodi
actual
dilut
calcul
post
acquisit
figur
actual
posit
event
defin
antibodyexpress
b
cell
among
beadbound
cell
use
evalu
potenti
specif
select
real
antigenspecif
cell
actual
true
event
defin
antigenspecif
b
cell
bound
bead
among
possibl
antibodyspecif
event
use
estim
select
antigenbind
cell
compar
specif
cell
sampl
observ
bead
abl
identifi
actual
posit
event
b
cell
specif
b
cell
frequenc
proport
actual
posit
event
antibodyexpress
b
cell
lower
specif
b
cell
frequenc
pbmc
pool
reduc
figur
c
actual
true
event
b
cell
bound
bead
among
possibl
antibodyexpress
event
rang
figur
c
bead
differ
type
diamet
size
vari
abil
detect
actual
posit
event
proport
actual
posit
event
among
beadbound
cell
decreas
frequenc
b
cell
lower
among
pbmc
antibodyexpress
b
cell
recogn
bead
antigenspecif
b
cell
found
high
frequenc
human
blood
sablu
lclc
biotin
bead
detect
highest
proport
b
cell
found
frequenc
figur
tabl
supplementari
materi
confirm
select
antibodyexpress
cell
specif
antibodi
pbmc
spike
show
bead
like
bead
recogn
cell
figur
figur
supplementari
materi
antibodyexpress
cell
also
less
like
detect
bead
pbmc
sampl
figur
similarli
bead
like
bind
trastuzumab
express
cell
compar
control
antibodyexpress
cell
bead
also
like
bind
trastuzumab
express
cell
compar
bead
show
low
bind
trastuzumab
express
cell
figur
human
ig
express
surfac
cell
shown
figur
supplementari
materi
togeth
data
suggest
antibodyexpress
cell
pbmc
prepar
abl
recogn
bead
conjug
specif
antigen
interrog
approach
human
set
evalu
whether
fluoresc
bead
conjug
melanoma
cell
surfac
antigen
abl
identifi
antigenreact
b
cell
prepar
fluoresc
bead
coat
antigen
extract
human
melanoma
cell
nativ
express
tumorassoci
antigen
chondroitin
sulfat
proteoglycan
melanoma
antigenco
bead
recogn
antibodi
antibodi
specif
antigen
express
cell
figur
supplementari
materi
suggest
antigenreact
antibodi
specif
recogn
antigen
bound
bead
screen
antigenreact
antibodi
human
b
cell
pbmc
patient
melanoma
incub
melanoma
antigenco
bead
screen
identifi
matur
b
cell
recogn
antigenco
bead
singl
beadbound
b
cell
isol
singl
cell
sort
ig
heavi
light
chain
sequenc
amplifi
sequenc
antibodi
clone
figur
b
antibodi
deriv
singl
beadbound
b
cell
could
recogn
melanoma
antigenco
fluoresc
bead
compar
secondari
nonspecif
antibodi
control
b
cellderiv
clone
show
bind
compar
monoclon
antibodi
specif
melanomaassoci
antigen
figur
taken
togeth
find
suggest
antigenreact
b
cell
human
blood
could
recogn
antigenconjug
fluoresc
bead
could
sort
flow
cytometri
express
monoclon
antibodi
report
present
develop
fluoresc
bead
method
select
singl
antigenreact
b
cell
clone
product
clone
antigenspecif
antibodi
downstream
test
workflow
compris
conjug
fluoresc
microspher
recombin
antigen
interest
b
identif
fluoresc
label
singl
antibodyexpress
b
cell
flow
cytometri
use
antigenconjug
bead
c
flow
cytometr
sort
beadbound
singl
cell
directli
lysi
buffer
singl
cell
retrotranscript
sequenc
match
heavi
light
chain
antibodi
variabl
region
e
clone
express
use
vector
contain
human
constant
region
cassett
f
confirm
antigen
reactiv
produc
fulllength
antibodi
design
process
allow
identif
antigenspecif
antibodyexpress
b
cell
without
requir
prior
ex
vivo
growth
secondari
screen
b
cell
aim
conduct
workflow
clone
identif
antibodi
product
character
timefram
approxim
day
design
protocol
employ
model
system
featur
human
recombin
folat
receptor
alpha
target
antigen
b
cell
line
express
solubl
membranebound
form
humanmous
chimer
antibodi
specif
show
fluoresc
microspher
coupl
recombin
antigen
via
bridg
immobil
antigen
could
readili
detect
antigenspecif
monoclon
antibodi
recognit
epitop
test
antibodi
thought
depend
nativ
fold
target
antigen
demonstr
possibl
use
antigencoupl
fluoresc
bead
differ
size
identifi
isol
singl
b
cell
express
cell
surfaceexpress
antibodi
recogn
conform
epitop
antigenantibodi
recognit
could
improv
evalu
bead
differ
characterist
diamet
vari
length
avidin
coupl
agent
significantli
influenc
antibodyexpress
cell
recognit
bead
latter
observ
also
suggest
engag
antigen
bead
surfac
via
differ
biotin
mask
epitop
recognit
specif
antibodi
either
solut
antibodi
express
surfac
b
cell
key
featur
beadbas
approach
principl
may
enabl
coupl
virtual
known
nativ
recombin
antigen
fluoresc
bead
facilit
detect
b
cell
reactiv
antigen
strategi
may
offer
differ
featur
compar
detect
method
instanc
antibodi
use
detect
bcr
b
cell
may
also
interact
bcr
also
fc
receptor
human
b
cell
tetram
technolog
may
applic
select
antigenspecif
b
cell
fluorophor
known
releas
antigen
complex
bind
nonspecif
immun
cell
yield
fals
posit
event
protocol
also
specif
design
avoid
requir
b
cell
cultur
ex
vivo
expans
antibodi
select
cultur
supernat
prior
subclon
limit
dilut
isol
antigenspecif
b
cell
clone
well
labori
lengthi
step
may
also
limit
specif
expans
distinct
b
cell
popul
alway
repres
origin
b
cell
repertoir
could
suffer
potenti
loss
antigenspecif
clone
cell
ex
vivo
cultur
process
follow
flow
sort
singl
cell
directli
lysi
buffer
confirm
possibl
extract
match
h
l
chain
variabl
region
sequenc
singl
antibodyexpress
cell
select
specif
antigenco
bead
employ
b
cell
model
confirm
b
cell
select
fluoresc
bead
allow
identif
match
variabl
region
permit
clone
product
correspond
monoclon
antibodi
singl
cell
greatli
expedit
use
singl
vector
cell
linebas
express
system
permit
antibodi
product
within
day
vector
use
studi
contain
constant
region
human
principl
platform
could
use
engin
b
cellderiv
antibodi
constant
region
isotyp
speci
desir
potenti
facilit
wide
rang
downstream
applic
technolog
importantli
show
clone
express
fulllength
antibodi
variabl
region
extract
singl
b
cell
could
recogn
nativ
cell
surfaceexpress
human
specif
identifi
antibodi
could
ultim
confirm
express
antibodi
subsequ
test
nativ
express
antigen
previou
publish
studi
report
number
detect
b
cell
antigen
reactiv
antibodi
secret
supernat
ex
vivo
b
cell
cultur
without
clone
product
test
deriv
antibodi
clone
similar
b
cell
identif
process
one
report
studi
describ
frequenc
antigenspecif
b
cell
detect
use
modifi
beadbas
method
tool
possibl
monitor
frequenc
antihla
antitetanu
toxin
b
cell
differ
individu
howev
antibodi
select
b
cell
often
clone
express
subsequ
order
analyz
abil
recogn
nativ
express
cognat
antigen
data
confirm
antibodi
sequenc
clone
express
antigen
recognit
provid
earli
proof
principl
function
ig
sequenc
could
recov
methodolog
ascertain
bind
fluoresc
bead
specif
singl
antibodyexpress
b
cell
found
bead
bound
possibl
igg
cell
howev
alongsid
enhanc
recognit
possibl
antigenreact
b
cell
bead
also
bound
nonspecif
b
cell
furthermor
proport
human
circul
b
cell
could
bind
bead
like
nonspecif
manner
togeth
suggest
background
nonspecif
bind
bead
cell
may
limit
methodolog
employ
two
approach
evalu
whether
antigencoupl
bead
could
detect
antigenreact
antibodyexpress
cell
pbmc
sampl
first
approach
spike
human
pbmc
b
cell
differ
frequenc
demonstr
fluoresc
bead
could
identifi
antibodyexpress
cell
among
pbmc
popul
antigenreact
cell
present
higher
frequenc
human
blood
also
found
differ
bead
type
differ
specif
recognit
background
recognit
profil
proport
actual
posit
b
cell
among
beadbound
cell
decreas
lower
frequenc
b
cell
among
pbmc
b
cell
found
high
frequenc
human
blood
proport
actual
posit
event
specif
b
cell
recogn
bead
rang
total
bound
cell
sablu
lclc
biotin
bead
abl
detect
highest
proport
although
fluoresc
activ
cell
sort
could
enabl
separ
singl
cell
heterogen
popul
detect
cell
popul
low
frequenc
remain
challeng
present
technic
limit
differ
protocol
consist
previou
studi
observ
great
variabl
acquir
number
cell
analyz
sampl
low
antigenspecif
b
cell
frequenc
impli
activ
high
frequenc
humor
respons
may
readili
studi
present
context
detect
low
frequenc
b
cell
repres
inher
limit
methodolog
requir
optim
next
step
ask
whether
use
protocol
fluoresc
bead
coat
melanoma
cell
line
antigen
may
abl
identifi
antigenreact
b
cell
individu
suffer
malign
melanoma
use
melanoma
cell
line
surfac
antigenco
fluoresc
bead
express
monoclon
antibodi
bound
melanoma
cell
line
proteinco
bead
suggest
antigenreact
b
cell
human
blood
may
singl
use
fluoresc
bead
select
singl
antigenspecif
b
cell
identif
express
antibodi
critic
gain
deeper
understand
natur
function
activ
human
humor
immun
respons
identif
b
cell
well
clone
product
heavi
light
chain
match
antigenspecif
monoclon
antibodi
thu
remain
highli
desir
immunolog
research
antibodi
discoveri
consequ
discoveri
antigenspecif
b
cell
clone
form
focu
numer
high
lowthroughput
approach
beadbas
protocol
may
provid
altern
readili
applic
mean
explor
human
b
cell
facilit
studi
singl
b
cellderiv
antibodi
function
profil
sinc
frequenc
antigenspecif
b
cell
human
circul
remain
total
b
cell
popul
increas
probabl
specif
select
lowfrequ
b
cell
remain
major
challeng
mani
avail
technolog
futur
effort
may
help
improv
specif
select
incorpor
addit
select
marker
bead
multipl
fluorophor
b
cell
activ
marker
singl
bcractiv
cell
like
matur
antibodyexpress
clone
altern
strategi
may
entail
addit
imag
tool
verifi
select
singl
antigenreact
b
cell
subsequ
cell
sort
furthermor
adjust
clone
process
identifi
antibodi
differ
subclass
specif
specif
b
cell
subset
could
improv
chanc
detect
clone
clonal
famili
certain
diseas
immunolog
condit
may
promot
specif
antibodi
profil
individu
combin
approach
may
help
increas
chanc
clonal
select
summari
describ
establish
methodolog
identifi
singl
antibodyexpress
cell
produc
test
sequenc
recombin
antibodi
workflow
may
readili
applic
basic
translat
immunolog
laboratori
set
singl
celltofunct
antibodi
strategi
may
open
way
new
opportun
analyz
b
cell
antibodi
profil
singl
cell
level
may
potenti
appli
help
unravel
divers
humor
immun
repertoir
blood
tissu
differ
health
diseas
condit
human
immun
cell
isol
venou
blood
human
volunt
specimen
collect
inform
written
consent
accord
declar
helsinki
sk
pk
kl
fn
conceiv
studi
ic
ki
sc
pk
kl
fn
sk
design
methodolog
ic
ki
pk
sc
sl
mf
ac
acquir
data
gener
materi
help
data
analysi
interpret
sk
pk
ki
ic
sc
wrote
manuscript
ic
ki
sc
sl
mf
ac
js
fn
pk
kl
sk
discuss
interpret
data
edit
manuscript
sk
supervis
studi
led
coordin
project
sk
js
founder
sharehold
igem
therapeut
ltd
fn
employe
sanofi
us
author
declar
conflict
interest
